These findings highlight an important role of M2-phenotype macrophages and their related cytokines in the progression of pulmonary fibrosis, and the TRPA1 inhibitor prevents the transition of macrophages to the M2 phenotype. Here, TRPA1 is linked to pulmonary fibrosis.